• Contemporary ClinicContemporary Clinic
  • OTC GuideOTC Guide
  • Pharmacy Times
  • PTCEPTCE
  • Pharmacist Moms GroupPharmacist Moms Group
News
All News
FDA Updates
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Publications
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
Clinical
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Events
Upcoming Events
Upcoming Webinars
CE
Resources
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
logo
Spotlight
Community/RetailHospitalOncologyPharmacy TechnicianStudent
Clinical Role
Community/RetailHospitalOncologyPharmacy TechnicianSpecialty PharmacyStudent
Clinical
CoronavirusBrain HealthCardiovascular HealthDermatologyDiabetesFluHeart FailureHepatitis/MASHImmunizationMigrainePneumococcalVitamins and Supplements
Supplement Spotlight
October 2023 Pharmacy Technician Edition
All News
FDA Updates
Press Releases
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conference Coverage
Conference Listing
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Upcoming Events
Upcoming Webinars
CE
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
Advertisement

CLINICAL ROLE -

Community/Retail
| Hospital
| Oncology
| Pharmacy Technician
| Student

Article

January 1, 2020

Survey Predicts Pharmacy Trends of 2020

Author(s):

Jill Murphy, Assistant Editor
Conference|ASHP Midyear Clinical Meeting and Exhibition - American Society of Health System Pharmacists Midyear Clinical Meeting and Exhibition

ASHP’s annual Pharmacy Forecast is designed to help advance pharmacy practice leadership, and to provide insight into the forecasted trends.

Emerging trends impacting health-system pharmacists were recently revealed during a session at the ASHP (American Society of Health-System Pharmacists) 54th Midyear Clinical Meeting & Exhibition in Las Vegas. The session highlighted ASHP’s annual Pharmacy Forecast, which is designed to help advance pharmacy practice leadership, and to provide insight into the forecasted trends.

In the 8th edition of the forecast, 325 forecast panelists were surveyed, with an 87.1% response rate, as explained by Lee Vermeulen, BSPharm, MS, FCCP, FFIP. The survey introduced 42 scenarios to the panelists, looking for the most “top of mind” response on a scale from “very likely” to “very unlikely.”

A new format, called ‘black swan,’ was incorporated this year, which looked at rare events that have massive consequences. This section provided 6 scenarios to explore how prepared individuals, organizations, and communities are to respond to black swan events in the coming years.

In patient-centered care, 43% of the panelists found that it would be “somewhat likely” that at least 25% of patients who are candidates for treatment with high-cost biologics, cancer chemotherapy, or other novel therapies will decide to forgo that treatment after weighing out-of-pocket costs, clinical benefits, and risks. Rita Shane, PharmD, FASHP, FCSHP, provided a recommendation to this subject, which would involve developing a roadmap to engage patients and care teams in shared decision-making discussions prior to therapy plan development.

Pharmacy workforce is heading in a positive direction in the next 5 years, according to the forecast. Forty-five percent of the panelists felt that it would be “somewhat likely” for at least 10 pharmacy schools to offer a combined physician assistant/PharmD program in the future. Shane recommended that health-systems collaborate with colleges and schools of pharmacy to develop a range of training options for pharmacists that would ensure an adequate supply of staff is capable of meeting the future needs of the health care system.

Another presenter, James. M. Hoffman, PharmD, MS, BCPS, FASHP, discussed pharmacy leadership trends that will arise in the next decade. The results in this section were close, with 39% of panelists feeling “somewhat likely,” and 38% of panelists feeling “somewhat unlikely” towards using a standardized performance model, similar to Magnet for nursing or HIMSS information technology adoption levels for information technology, will be developed to distinguish certain pharmacy departments as centers of excellences.

In pharmaceutical supply chain, 40% of panelists were feeling “somewhat likely,” and 42% feeling “somewhat unlikely” towards federal law incentivizing active pharmaceutical ingredients (API) production in the United States in the future. A recommendation for this subject, presented by Erin R. Fox, PharmD, BCPS, FASHP, is to purchase pharmaceutical products produced in the US or European Union whenever possible. In addition, Fox mentioned that when signing local drug acquisition contracts, pharmacy professionals should insist on disclosure of the source and site of manufacture, ensuring that contracts signed by group purchasing organizations on behalf of health systems also include disclosure.

One of the black swan questions in this year’s Pharmacy Forecast asked panelists, “what percentage of health-systems pharmacists in your region are currently capable of taking the event in stride and successfully adapting in response?” Fifty-five of the panelists answered that 41-50% of health-system pharmacists fit this description, and 45 of the panelists answered that 21-30% of health-system pharmacists fit this description.

Scott J. Knoer, MS, PharmD, FASHP, recommended increasing the relative attention given to long-term strategic issues in the pharmacy department’s planning process. Using annual Pharmacy Forecast reports can help to stimulate this shift, according to Knoer.

REFERENCE

Vermeulen L, Shane R, Hoffman J, et al. Pharmacy forecast 2020: trends that will shape your future. Presented at: American Society of Health-System Pharmacists 54th Midyear Clinical Meeting and Exhibition; Las Vegas, Nevada: December 12, 2019.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Tired scared retiree man holding chest with anginal symptoms, pallor and diaphoresis at home. Suffering male with cardiac origin pain, prexcordial pressure, arrhythmia risk, urgent medical attention - Image credit: DimaBerlin | stock.adobe.com
Image credit: Sebastian Kaulitzki | stock.adobe.com
Magnified bone marrow biopsy showing plasma cells with irregular nuclei and multiple myeloma tumor cells infiltrating normal hematopoietic tissue
Related Content
Advertisement
Hyperlipidemia concept showing artery with plaque buildup and blood flow disruption in detailed medical illustration
June 13th 2025

Enlicitide Decanoate Demonstrates Meaningful Reductions in LDL-C

Luke Halpern, Assistant Editor
S2. Ep 56: Insights From a Pharmacy Times Peer Exchange: How to Talk the Talk
June 3rd 2025

S2. Ep 56: Insights From a Pharmacy Times Peer Exchange: How to Talk the Talk

Alexandra Gerlach, Associate Editor
Woman with a pink ribbon for breast cancer awareness -- Image credit: Phongsakorn | stock.adobe.com
June 13th 2025

ASCO 2025: Ribociclib With NSAI in HR+/HER– Breast Cancer Improves iDFS, Yields Substantial Work Productivity Gains

Gillian McGovern, Associate Editor
Insights from a Pharmacy Times Peer Exchange: Toxicity Monitoring and Management in Real-World Settings
May 28th 2025

Insights from a Pharmacy Times Peer Exchange: Toxicity Monitoring and Management in Real-World Settings

Alexandra Gerlach, Associate Editor
Blood smears showing increased counts of lymphocytes | Image Credit: © DigitalDruid - stock.adobe.com
June 13th 2025

Five-Year Data Show Sustained Efficacy of Zanubrutinib in CLL With High Response Rates

Alexandra Gerlach, Associate Editor
The Evolving Role of the Pharmacist in HEOR: Bridging Clinical and Economic Evidence
June 13th 2025

The Evolving Role of the Pharmacist in HEOR: Bridging Clinical and Economic Evidence

Muhammad Cheema, PharmD, MPBA
Related Content
Advertisement
Hyperlipidemia concept showing artery with plaque buildup and blood flow disruption in detailed medical illustration
June 13th 2025

Enlicitide Decanoate Demonstrates Meaningful Reductions in LDL-C

Luke Halpern, Assistant Editor
S2. Ep 56: Insights From a Pharmacy Times Peer Exchange: How to Talk the Talk
June 3rd 2025

S2. Ep 56: Insights From a Pharmacy Times Peer Exchange: How to Talk the Talk

Alexandra Gerlach, Associate Editor
Woman with a pink ribbon for breast cancer awareness -- Image credit: Phongsakorn | stock.adobe.com
June 13th 2025

ASCO 2025: Ribociclib With NSAI in HR+/HER– Breast Cancer Improves iDFS, Yields Substantial Work Productivity Gains

Gillian McGovern, Associate Editor
Insights from a Pharmacy Times Peer Exchange: Toxicity Monitoring and Management in Real-World Settings
May 28th 2025

Insights from a Pharmacy Times Peer Exchange: Toxicity Monitoring and Management in Real-World Settings

Alexandra Gerlach, Associate Editor
Blood smears showing increased counts of lymphocytes | Image Credit: © DigitalDruid - stock.adobe.com
June 13th 2025

Five-Year Data Show Sustained Efficacy of Zanubrutinib in CLL With High Response Rates

Alexandra Gerlach, Associate Editor
The Evolving Role of the Pharmacist in HEOR: Bridging Clinical and Economic Evidence
June 13th 2025

The Evolving Role of the Pharmacist in HEOR: Bridging Clinical and Economic Evidence

Muhammad Cheema, PharmD, MPBA
Consent Preferences
About Us
Clinical Forums
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.